Business
PharmaEssentia USA Announces Appointment of Jeffrey Williams as Independent Director
BURLINGTON, Mass., December 24, 2025--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, announced the appointment of Jeffrey R. Williams as Independent Director.
About this update from Pharmaessentia Corp.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":16834,"height":5437,"url":"https://media.zenfs.com/en/business-wire.com/bf5e66f59e874bf1533cc91f37e5e533"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/OpeWi1r5JZnChAe_WejC2A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMxMDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/bf5e66f59e874bf1533cc91f37e5e533","width":960,"height":310},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/i1RGw1.gXA4qZNAgo2C8Yw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD03NzY7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/bf5e66f59e874bf1533cc91f37e5e533","width":1200,"height":388}},"lazy":false},{"type":"text","content":"Seasoned global finance and governance leader joins Board to support the company’s continued global expansion","length":109,"tagName":"p","attribs":{}},{"type":"text","content":"BURLINGTON, Mass., December 24, 2025--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, announced the appointment of Jeffrey R. Williams as Independent Director.","length":382,"tagName":"p"},{"type":"text","content":""We are pleased to welcome Jeffrey to our Board of Directors for PharmaEssentia USA," said Ko-Chung Lin, Ph.D., Founder and Chief Executive Officer. "Jeffrey’s global governance and financial acumen, along with his deep understanding of the East Asian market, will be instrumental as we continue to strengthen our international footprint and deliver innovation to patients worldwide."","length":404,"tagName":"p"},{"type":"text","content":"Mr. Williams is a seasoned corporate and nonprofit director with decades of experience in global finance, governance, and philanthropy, with a career deeply rooted in East Asia. He has served as an Independent Director of PharmaEssentia Corporation in Taiwan since May 2024 and brings valuable regional insight to the PharmaEssentia USA Board.","length":343,"tagName":"p"},{"type":"text","content":"He currently serves as Director of UBS SDIC Fund Management Company, UBS Asset Management (China), and Koo Foundation Cancer Center Hospital. He is a...